482 related articles for article (PubMed ID: 31813629)
1. Gut microbiota manipulation through probiotics oral administration restores glucose homeostasis in a mouse model of Alzheimer's disease.
Bonfili L; Cecarini V; Gogoi O; Berardi S; Scarpona S; Angeletti M; Rossi G; Eleuteri AM
Neurobiol Aging; 2020 Mar; 87():35-43. PubMed ID: 31813629
[TBL] [Abstract][Full Text] [Related]
2. Impaired Glucose Tolerance and Reduced Plasma Insulin Precede Decreased AKT Phosphorylation and GLUT3 Translocation in the Hippocampus of Old 3xTg-AD Mice.
Griffith CM; Macklin LN; Cai Y; Sharp AA; Yan XX; Reagan LP; Strader AD; Rose GM; Patrylo PR
J Alzheimers Dis; 2019; 68(2):809-837. PubMed ID: 30775979
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota modulation in Alzheimer's disease: Focus on lipid metabolism.
Bonfili L; Cuccioloni M; Gong C; Cecarini V; Spina M; Zheng Y; Angeletti M; Eleuteri AM
Clin Nutr; 2022 Mar; 41(3):698-708. PubMed ID: 35158177
[TBL] [Abstract][Full Text] [Related]
4. Activation of brain glucose metabolism ameliorating cognitive impairment in APP/PS1 transgenic mice by electroacupuncture.
Liu W; Zhuo P; Li L; Jin H; Lin B; Zhang Y; Liang S; Wu J; Huang J; Wang Z; Lin R; Chen L; Tao J
Free Radic Biol Med; 2017 Nov; 112():174-190. PubMed ID: 28756309
[TBL] [Abstract][Full Text] [Related]
5. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer's disease animal model.
Kim MS; Kim Y; Choi H; Kim W; Park S; Lee D; Kim DK; Kim HJ; Choi H; Hyun DW; Lee JY; Choi EY; Lee DS; Bae JW; Mook-Jung I
Gut; 2020 Feb; 69(2):283-294. PubMed ID: 31471351
[TBL] [Abstract][Full Text] [Related]
6. Probiotics ameliorate intestinal pathophysiology in a mouse model of Alzheimer's disease.
Kaur H; Nagamoto-Combs K; Golovko S; Golovko MY; Klug MG; Combs CK
Neurobiol Aging; 2020 Aug; 92():114-134. PubMed ID: 32417748
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of Akkermansia muciniphila on cognitive deficits and amyloid pathology in a mouse model of Alzheimer's disease.
Ou Z; Deng L; Lu Z; Wu F; Liu W; Huang D; Peng Y
Nutr Diabetes; 2020 Apr; 10(1):12. PubMed ID: 32321934
[TBL] [Abstract][Full Text] [Related]
8. Strategic Modification of Gut Microbiota through Oral Bacteriotherapy Influences Hypoxia Inducible Factor-1α: Therapeutic Implication in Alzheimer's Disease.
Bonfili L; Gong C; Lombardi F; Cifone MG; Eleuteri AM
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008786
[TBL] [Abstract][Full Text] [Related]
9. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
[TBL] [Abstract][Full Text] [Related]
10. P-coumaric acid ameliorates Aβ
Cao B; Zeng MN; Hao FX; Hao ZY; Zhang ZK; Liang XW; Wu YY; Zhang YH; Feng WS; Zheng XK
Biomed Pharmacother; 2023 Dec; 168():115825. PubMed ID: 37924791
[TBL] [Abstract][Full Text] [Related]
11. Bioactive Food Abates Metabolic and Synaptic Alterations by Modulation of Gut Microbiota in a Mouse Model of Alzheimer's Disease.
Syeda T; Sanchez-Tapia M; Pinedo-Vargas L; Granados O; Cuervo-Zanatta D; Rojas-Santiago E; Díaz-Cintra SA; Torres N; Perez-Cruz C
J Alzheimers Dis; 2018; 66(4):1657-1682. PubMed ID: 30475761
[TBL] [Abstract][Full Text] [Related]
12. Effect of Clostridium butyricum against Microglia-Mediated Neuroinflammation in Alzheimer's Disease via Regulating Gut Microbiota and Metabolites Butyrate.
Sun J; Xu J; Yang B; Chen K; Kong Y; Fang N; Gong T; Wang F; Ling Z; Liu J
Mol Nutr Food Res; 2020 Jan; 64(2):e1900636. PubMed ID: 31835282
[TBL] [Abstract][Full Text] [Related]
13. Regular Exercise Enhances Cognitive Function and Intracephalic GLUT Expression in Alzheimer's Disease Model Mice.
Pang R; Wang X; Pei F; Zhang W; Shen J; Gao X; Chang C
J Alzheimers Dis; 2019; 72(1):83-96. PubMed ID: 31561359
[TBL] [Abstract][Full Text] [Related]
14. Bee venom phospholipase A2 ameliorates Alzheimer's disease pathology in Aβ vaccination treatment without inducing neuro-inflammation in a 3xTg-AD mouse model.
Baek H; Lee CJ; Choi DB; Kim NS; Kim YS; Ye YJ; Kim YS; Kim JS; Shim I; Bae H
Sci Rep; 2018 Nov; 8(1):17369. PubMed ID: 30478329
[TBL] [Abstract][Full Text] [Related]
15. Evidence for brain glucose dysregulation in Alzheimer's disease.
An Y; Varma VR; Varma S; Casanova R; Dammer E; Pletnikova O; Chia CW; Egan JM; Ferrucci L; Troncoso J; Levey AI; Lah J; Seyfried NT; Legido-Quigley C; O'Brien R; Thambisetty M
Alzheimers Dement; 2018 Mar; 14(3):318-329. PubMed ID: 29055815
[TBL] [Abstract][Full Text] [Related]
16. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
[TBL] [Abstract][Full Text] [Related]
17. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
18. Effects of Chronic Arginase Inhibition with Norvaline on Tau Pathology and Brain Glucose Metabolism in Alzheimer's Disease Mice.
Polis B; Squillario M; Gurevich V; Srikanth KD; Assa M; Samson AO
Neurochem Res; 2022 May; 47(5):1255-1268. PubMed ID: 35098420
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota and pro/prebiotics in Alzheimer's disease.
Pluta R; Ułamek-Kozioł M; Januszewski S; Czuczwar SJ
Aging (Albany NY); 2020 Mar; 12(6):5539-5550. PubMed ID: 32191919
[TBL] [Abstract][Full Text] [Related]
20. Microbiota modulation as preventative and therapeutic approach in Alzheimer's disease.
Bonfili L; Cecarini V; Gogoi O; Gong C; Cuccioloni M; Angeletti M; Rossi G; Eleuteri AM
FEBS J; 2021 May; 288(9):2836-2855. PubMed ID: 32969566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
